vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $250.2M, roughly 1.3× USANA HEALTH SCIENCES INC). Andersons, Inc. runs the higher net margin — 20.5% vs 3.0%, a 17.5% gap on every dollar of revenue. On growth, Andersons, Inc. posted the faster year-over-year revenue change (-2.4% vs -3.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
ANDE vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $250.2M |
| Net Profit | $67.4M | $7.5M |
| Gross Margin | 70.3% | 76.2% |
| Operating Margin | 26.6% | 5.5% |
| Net Margin | 20.5% | 3.0% |
| Revenue YoY | -2.4% | -3.0% |
| Net Profit YoY | 49.6% | -20.0% |
| EPS (diluted) | — | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | $329.5M | $226.2M | ||
| Q3 25 | $295.8M | $213.7M | ||
| Q2 25 | $535.0M | $235.8M | ||
| Q1 25 | $370.8M | $249.5M | ||
| Q4 24 | $337.5M | $213.6M | ||
| Q3 24 | $231.9M | $200.2M | ||
| Q2 24 | $492.5M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | $67.4M | $180.0K | ||
| Q3 25 | $20.1M | $-6.5M | ||
| Q2 25 | $7.9M | $9.7M | ||
| Q1 25 | $284.0K | $9.4M | ||
| Q4 24 | $45.1M | $4.5M | ||
| Q3 24 | $27.4M | $10.6M | ||
| Q2 24 | $36.0M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | 70.3% | 78.2% | ||
| Q3 25 | 57.8% | 77.2% | ||
| Q2 25 | 29.6% | 78.7% | ||
| Q1 25 | 41.2% | 79.0% | ||
| Q4 24 | 63.1% | 82.0% | ||
| Q3 24 | 76.4% | 80.4% | ||
| Q2 24 | 35.6% | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | 26.6% | 1.7% | ||
| Q3 25 | 8.7% | 0.6% | ||
| Q2 25 | 4.6% | 7.1% | ||
| Q1 25 | 0.9% | 6.3% | ||
| Q4 24 | 19.9% | 3.8% | ||
| Q3 24 | 26.8% | 7.8% | ||
| Q2 24 | 11.6% | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | 20.5% | 0.1% | ||
| Q3 25 | 6.8% | -3.1% | ||
| Q2 25 | 1.5% | 4.1% | ||
| Q1 25 | 0.1% | 3.8% | ||
| Q4 24 | 13.4% | 2.1% | ||
| Q3 24 | 11.8% | 5.3% | ||
| Q2 24 | 7.3% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | — | $-0.10 | ||
| Q3 25 | $0.59 | $-0.36 | ||
| Q2 25 | $0.23 | $0.52 | ||
| Q1 25 | $0.01 | $0.49 | ||
| Q4 24 | $1.31 | $0.23 | ||
| Q3 24 | $0.80 | $0.56 | ||
| Q2 24 | $1.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $162.8M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | — |
| Total Assets | $3.7B | $739.0M |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | $98.3M | $158.4M | ||
| Q3 25 | — | $145.3M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | $561.8M | $181.8M | ||
| Q3 24 | — | $364.9M | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $528.1M | ||
| Q2 25 | $1.4B | $531.1M | ||
| Q1 25 | $1.4B | $529.8M | ||
| Q4 24 | $1.4B | $532.1M | ||
| Q3 24 | $1.3B | $533.1M | ||
| Q2 24 | $1.3B | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | $3.7B | $742.9M | ||
| Q3 25 | $3.3B | $726.6M | ||
| Q2 25 | $3.4B | $734.5M | ||
| Q1 25 | $3.8B | $746.6M | ||
| Q4 24 | $4.1B | $748.2M | ||
| Q3 24 | $3.4B | $671.3M | ||
| Q2 24 | $3.3B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | — |
| Free Cash FlowOCF − Capex | $-77.1M | — |
| FCF MarginFCF / Revenue | -23.4% | — |
| Capex IntensityCapex / Revenue | 21.5% | — |
| Cash ConversionOCF / Net Profit | -0.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-6.2M | — | ||
| Q3 25 | $233.9M | $-2.0M | ||
| Q2 25 | $299.3M | $12.2M | ||
| Q1 25 | $-350.0M | $15.5M | ||
| Q4 24 | $268.8M | $5.8M | ||
| Q3 24 | $-2.1M | $29.5M | ||
| Q2 24 | $304.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-77.1M | — | ||
| Q3 25 | $167.0M | $-5.2M | ||
| Q2 25 | $250.5M | $7.2M | ||
| Q1 25 | $-396.6M | $12.7M | ||
| Q4 24 | $212.9M | $4.0M | ||
| Q3 24 | $-40.0M | $27.1M | ||
| Q2 24 | $275.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | -23.4% | — | ||
| Q3 25 | 56.5% | -2.4% | ||
| Q2 25 | 46.8% | 3.0% | ||
| Q1 25 | -106.9% | 5.1% | ||
| Q4 24 | 63.1% | 1.9% | ||
| Q3 24 | -17.2% | 13.6% | ||
| Q2 24 | 56.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 22.6% | 1.5% | ||
| Q2 25 | 9.1% | 2.1% | ||
| Q1 25 | 12.6% | 1.1% | ||
| Q4 24 | 16.6% | 0.8% | ||
| Q3 24 | 16.3% | 1.2% | ||
| Q2 24 | 5.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.09× | — | ||
| Q3 25 | 11.61× | — | ||
| Q2 25 | 38.10× | 1.27× | ||
| Q1 25 | -1232.46× | 1.65× | ||
| Q4 24 | 5.96× | 1.29× | ||
| Q3 24 | -0.08× | 2.78× | ||
| Q2 24 | 8.46× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
USNA
Segment breakdown not available.
